JAHA::一个全新的自发性肺动脉高压小鼠模型

2021-11-03 刘少飞 MedSci原创

SIRT3(脱乙酰酶)和 UCP2(非典型解偶联蛋白)的孤立功能丧失单核苷酸多态性 (SNP) 与肺动脉高压 (PAH) 和胰岛素抵抗有关,研究提供了一种新的 PAH 小鼠模型及其PAH 小鼠特征。

肺动脉高压 (PAH) 的特征是肺动脉重塑,导致管腔闭塞,增加肺血管阻力 (PVR)。 虽然最初这会导致右心室 (RV) 肥大,但随后会导致 RV 扩张并因 RV 衰竭而死亡。关于PAH的代谢理论表明,线粒体抑制是一个关键的早期事件,它也有可能激活许多与 PAH 相关的转录因子。线粒体氧化磷酸化(葡萄糖氧化)的抑制是 T 细胞活化的早期和必要事件。事实上,在 PAH 患者的骨骼肌活检中,有证据表明存在线粒体功能障碍(线粒体酶下调和糖酵解酶上调)。研究发现,缺乏 Sirt3 (sirtuin3)11(一种主要的线粒体脱乙酰酶)或 Ucp2(解偶联蛋白 2)(一种主要促进钙进入线粒体的非典型解偶联蛋白)的 KO 小鼠发生了自发性肺动脉高压(PHT)和血管重塑。

本研究目的:针对SIRT3和 UCP2的孤立功能丧失单核苷酸多态性及胰岛素抵抗的动物模型及患者的探索。

研究方法:
在 PAH 患者(n=60)的前瞻性队列中,该研究测量了 SIRT3 和 UCP2 的 SNP,以及几个临床特征,包括侵入性血流动力学数据。

 

研究结果:该研究发现 SIRT3 和 UCP2 SNP 通常以纯合子或杂合子的方式出现在同一患者中,与 PAH 的严重程度呈正相关,并与 2 型糖尿病的存在和10 年结果(死亡和移植)相关。

PAH 患者中的 SIRT3 和 UCP2 单核苷酸多态性 (SNP)

Sirt3 和 Ucp2 缺失对小鼠杂合子或纯合子 PAH 严重程度的基因剂量依赖性影响

Sirt3 和 Ucp2 缺失的杂合子或纯合子小鼠的肺血管重塑

缺乏 Sirt3 和 Ucp2 的小鼠的丛样动脉病变

来自Sirt3 和 Ucp2 的缺失小鼠杂合子或纯合子的培养的 PASMC 的增殖和抗凋亡表型

缺乏 Sirt3 和 Ucp2 的小鼠 PASMC 的代谢重塑

 

为了从机制上探索这一点,以上是针对 Sirt3 和 Ucp2 生成了双敲除小鼠,并发现 PAH 的严重程度增加(平均肺动脉压力、右心室肥大/扩张和广泛的血管重塑,包括炎症性丛样病变,以基因剂量依赖性方式),以及胰岛素抵抗,与野生型小鼠相比。与野生型小鼠相比,双敲除肺动脉平滑肌细胞的线粒体功能受到抑制(呼吸减少、线粒体膜电位增加)与细胞凋亡抵抗和增殖增加有关。

研究结论:
该研究发现支持PAH 的代谢理论,并表明这些小鼠表现出模仿人类 PAH 的自发性严重 PAH(没有环境或化学触发因素),并且可以解释我们患者队列中的发现。研究提供了一种新的 PAH 小鼠模型,具有其他 PAH 小鼠模型中通常不存在的人类疾病的几个特征。该小鼠模型支持我们队列中具有挑战性的临床数据,并且与在编码线粒体蛋白的基因中携带超过 1 个功能丧失 SNP 的 PAH 患者亚组直接相关,特别是那些在两个等位基因中都携带它们的基因。

 

文献出处:

Zhang Y, Zervopoulos SD, Boukouris AE, Lorenzana-Carrillo MA, Saleme B, Webster L, Liu Y, Haromy A, Tabatabaei Dakhili SA, Ussher JR, Sutendra G, Michelakis ED. SNPs for Genes Encoding the Mitochondrial Proteins Sirtuin3 and Uncoupling Protein 2 Are Associated With Disease Severity, Type 2 Diabetes, and Outcomes in Patients With Pulmonary Arterial Hypertension and This Is Recapitulated in a New Mouse Model Lacking Both Genes. J Am Heart Assoc. 2021 Oct 30:e020451. doi: 10.1161/JAHA.120.020451. Epub ahead of print. PMID: 34719264.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1925471, encodeId=8ff619254e154, content=<a href='/topic/show?id=26d633354c9' target=_blank style='color:#2F92EE;'>#动脉高压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33354, encryptionId=26d633354c9, topicName=动脉高压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44a360, createdName=jklm09, createdTime=Tue Dec 28 04:18:09 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1268663, encodeId=a9b5126866311, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Thu Nov 04 12:18:09 CST 2021, time=2021-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1436816, encodeId=1b0f14368169e, content=<a href='/topic/show?id=a9424e199a5' target=_blank style='color:#2F92EE;'>#小鼠模型#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47199, encryptionId=a9424e199a5, topicName=小鼠模型)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Thu Nov 04 12:18:09 CST 2021, time=2021-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1530640, encodeId=d6b715306408f, content=<a href='/topic/show?id=ed4a860e872' target=_blank style='color:#2F92EE;'>#自发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86078, encryptionId=ed4a860e872, topicName=自发性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=584a12117168, createdName=sodoo, createdTime=Thu Nov 04 12:18:09 CST 2021, time=2021-11-04, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1925471, encodeId=8ff619254e154, content=<a href='/topic/show?id=26d633354c9' target=_blank style='color:#2F92EE;'>#动脉高压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33354, encryptionId=26d633354c9, topicName=动脉高压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44a360, createdName=jklm09, createdTime=Tue Dec 28 04:18:09 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1268663, encodeId=a9b5126866311, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Thu Nov 04 12:18:09 CST 2021, time=2021-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1436816, encodeId=1b0f14368169e, content=<a href='/topic/show?id=a9424e199a5' target=_blank style='color:#2F92EE;'>#小鼠模型#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47199, encryptionId=a9424e199a5, topicName=小鼠模型)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Thu Nov 04 12:18:09 CST 2021, time=2021-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1530640, encodeId=d6b715306408f, content=<a href='/topic/show?id=ed4a860e872' target=_blank style='color:#2F92EE;'>#自发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86078, encryptionId=ed4a860e872, topicName=自发性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=584a12117168, createdName=sodoo, createdTime=Thu Nov 04 12:18:09 CST 2021, time=2021-11-04, status=1, ipAttribution=)]
    2021-11-04 zhaohui6731
  3. [GetPortalCommentsPageByObjectIdResponse(id=1925471, encodeId=8ff619254e154, content=<a href='/topic/show?id=26d633354c9' target=_blank style='color:#2F92EE;'>#动脉高压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33354, encryptionId=26d633354c9, topicName=动脉高压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44a360, createdName=jklm09, createdTime=Tue Dec 28 04:18:09 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1268663, encodeId=a9b5126866311, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Thu Nov 04 12:18:09 CST 2021, time=2021-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1436816, encodeId=1b0f14368169e, content=<a href='/topic/show?id=a9424e199a5' target=_blank style='color:#2F92EE;'>#小鼠模型#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47199, encryptionId=a9424e199a5, topicName=小鼠模型)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Thu Nov 04 12:18:09 CST 2021, time=2021-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1530640, encodeId=d6b715306408f, content=<a href='/topic/show?id=ed4a860e872' target=_blank style='color:#2F92EE;'>#自发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86078, encryptionId=ed4a860e872, topicName=自发性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=584a12117168, createdName=sodoo, createdTime=Thu Nov 04 12:18:09 CST 2021, time=2021-11-04, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1925471, encodeId=8ff619254e154, content=<a href='/topic/show?id=26d633354c9' target=_blank style='color:#2F92EE;'>#动脉高压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33354, encryptionId=26d633354c9, topicName=动脉高压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44a360, createdName=jklm09, createdTime=Tue Dec 28 04:18:09 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1268663, encodeId=a9b5126866311, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Thu Nov 04 12:18:09 CST 2021, time=2021-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1436816, encodeId=1b0f14368169e, content=<a href='/topic/show?id=a9424e199a5' target=_blank style='color:#2F92EE;'>#小鼠模型#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47199, encryptionId=a9424e199a5, topicName=小鼠模型)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Thu Nov 04 12:18:09 CST 2021, time=2021-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1530640, encodeId=d6b715306408f, content=<a href='/topic/show?id=ed4a860e872' target=_blank style='color:#2F92EE;'>#自发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86078, encryptionId=ed4a860e872, topicName=自发性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=584a12117168, createdName=sodoo, createdTime=Thu Nov 04 12:18:09 CST 2021, time=2021-11-04, status=1, ipAttribution=)]
    2021-11-04 sodoo

相关资讯

AJRCCM:什么是1型神经纤维瘤病相关肺动脉高压?

与 1 型神经纤维瘤病 (NF1)相关的肺动脉高压(PH)是一种罕见但严重的 NF1 并发症。PH-NF1 患者的特征和结果在很大程度上是未知的,该研究集中报道了其表型和转归情况。

杂合子原调蛋白3小鼠可改善慢性缺氧后肺血管化

高海拔 (HA) 环境施加强大的选择压力,导致在进化过程中涉及遗传、表观遗传和生理变化的适应。前期测序发现基因Tropomodulin-3在高原人口中高表达,该研究检测该基因的体内功能作用。

ARJCCM:肺动脉高压右室-动脉耦联的评价及预后相关性

肺动脉高压右室-动脉耦联的评价是针对右心脏功能与外周血管功能的相互匹配关系的重要手段。通过调整相匹配的动脉性能,对肺动脉高压中严重的右心衰竭进行整体的评估及预后的相关性可作为肺动脉高压患者预后的参考。

AJRCCM:肺动脉高压不同人群的存活率

关于肺动脉高压 (PAH) 疾病表现和结果的种族/民族差异的可用信息有限。尽管对欧洲血统样本中遗传变异的影响进行了全面调查,但种族/民族对第1组PAH的死亡率、功能状态和疾病严重程度的影响尚不可知。

AJRCCM:NUDT1清除氧化DNA前体参与肺动脉高压的血管重塑

为了揭示与肺动脉高压疾病的有关的新分子,对来自对照和 PAH 患者的分离的肺动脉平滑肌进行了无偏见和定量的蛋白质组学分析。实验表明NUDT1 的药理学抑制在肺动脉高压动物模型中具有结构和血流动力益处。

AJRCCM:大鼠肺动脉高压模型的单细胞测序研究新发现

鉴于在 PAH 动物模型中测试的许多新疗法尚未转化为床边,需要更全面地了解这些模型的细胞和分子景观,以阐明机制见解并增强临床前工作预测药物疗效的能力在人类。